MannKind Corporation [NASDAQ: MNKD] loss -0.24% on the last trading session, reaching $4.15 price per share at the time. The company report on October 18, 2021 that Progress Update on Tyvaso DPI™ New Drug Application. Complete response received by United Therapeutics cites an open inspection